NCT05840224 2026-01-28Study of GS-4528 in Adults With Solid TumorsGilead SciencesPhase 1 Active not recruiting182 enrolled
NCT05007782 2025-12-29Study of Denikitug (GS-1811) Given Alone or With Zimberelimab in Adults With Advanced Solid TumorsGilead SciencesPhase 1 Recruiting416 enrolled
NCT06082960 2025-09-10Study of GS-9911 With or Without Antibody Treatment for Adults With Solid TumorsGilead SciencesPhase 1 Active not recruiting45 enrolled
NCT06532565 2025-05-16Study of GS-2121 Given Alone or in Combination in Adults With Advanced Solid TumorsGilead SciencesPhase 1 Recruiting154 enrolled
NCT03628677 2025-02-04A Study to Evaluate the Safety and Tolerability of AB154 in Participants With Advanced MalignanciesArcus Biosciences, Inc.Phase 1 Completed75 enrolled
NCT04087018 2024-09-19Study to Evaluate Safety and Clinical Activity of AB122 in Biomarker Selected Participants With Advanced Solid TumorsArcus Biosciences, Inc.Phase 1 Completed18 enrolled
NCT04747470 2024-09-03Study to Assess the Effects of GS-3583 in Participants With Advanced Solid TumorsGilead SciencesPhase 1 Terminated13 enrolled 18 charts